Being one of the top local pharmaceutical manufacturing companies in the region, and as part of its mission to cater for the continuous needs of the pharmaceutical sector, Tabuk- through its high caliber regulatory department and the strong relationship built with the health authorities- had received registration approvals for twenty six (26) more products in different therapeutic categories in the different MENA countries. These approvals should enable Tabuk to further penetrate cardiovascular, anti-infective, antifungal, CNS and analgesics categories, and thus allowing for a higher market share, hence a long term leading position.